TRANSLOCATION RENAL CELL CARCINOMA
Clinical trials for TRANSLOCATION RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new TRANSLOCATION RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for TRANSLOCATION RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Supercharged immune cells take on Hard-to-Treat cancers
Disease control OngoingThis early-phase study tests whether a new immune cell therapy, called memory-like natural killer (NK) cells, can be safely given to people with advanced kidney or bladder cancers. The treatment involves collecting a patient's own immune cells, boosting them with special proteins…
Matched conditions: TRANSLOCATION RENAL CELL CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 26, 2026 09:26 UTC
-
New drug cocktail shows promise in slowing tough kidney cancers
Disease control OngoingThis study tests whether a combination of three drugs (cabozantinib, nivolumab, and ipilimumab) can safely slow the growth of advanced kidney cancer that has spread. About 60 adults with certain types of kidney cancer that cannot be removed by surgery will receive the treatment. …
Matched conditions: TRANSLOCATION RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Bradley A. McGregor, MD • Aim: Disease control
Last updated May 22, 2026 14:05 UTC